Obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years, gender is not limited; 2. BMI 27.5-40 kg/m^2; 3. Those who have tried other weight loss methods in the past but are not satisfied with the effect; 4. Willing to comply with research requirements, including willingness to avoid the use of drugs or other substances for weight loss during the follow-up study; 5. Right-handed, avoid the use of antibiotics and probiotics within 1 month before enrollment; 6. Be able to take proton pump inhibitors and antiemetics as prescribed by the investigator; 7. Can walk completely independently without any serious chronic orthopedic diseases; 8. Willingness to avoid the use of non-steroidal anti-inflammatory drugs during the study period, including aspirin, diclofenac, ibuprofen, naproxen or other known gastric irritating drugs; 9. Willing to accept gastroscopy.
Exclusion criteria
Exclusion criteria: 1. Patients with past or current diagnosis of ketoacidosis; 2. Symptomatic congestive heart failure, arrhythmia or unstable coronary artery disease; 3. Currently suffering from respiratory diseases such as chronic obstructive pulmonary disease (COPD), pneumonia or lung cancer; 4. Received bariatric surgery before enrolling in the study, or may undergo bariatric surgery during the study; 5. Have used intragastric medical devices to lose weight before entering the study; 6. Suffered from acute or chronic pancreatitis within 12 months before entering the study; 7. Past or current history of small bowel obstruction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body Mass Index; | — |
Countries
China
Contacts
The Third Xiangya Hospital of Central South University